Omicron BF.7 first case in India was detected in October. So far, two cases have been reported from Gujarat while one case has been reported from Odisha.
The Omicron BF.7 strain, a new Covid-19 strain that has wreaked havoc in China, has arrived in India too, though. In the last six months, four cases of the Omicron BF.7 strain have been identified in India. The infecting strain has been identified in the Indian states of Gujarat (2) and Odisha (1). Unlike in China, the new coronavirus subtype has not yet affected many people, but the Center has warned all states and union territories to be on the lookout. In India, strict security arrangements are being made to combat the coronavirus, which cannot be ignored.
The recent surge of Covid-19 across China, which has left the World Health Organization “very concerned” and revived fears across the world, including India, is due to the highly infectious Omicron strain BF.7, which has been identified in Beijing Diffuse is the main type.
Today on Thursday, Prime Minister Narendra Modi held a high-level meeting to review the Covid-19 situation in the country and aspects related to it.
What is BF.7 ?
This variant is a mutant of Omicron and has one of the highest transmissibility among all Covid variants. According to research studies, the R0 value of this mutant is around 10-18.6 which means that any infected person can easily infect 10-18.6 people around him.
People who have not been vaccinated or whose immunity is weak, such as elderly citizens and young children, are at great risk of this infection. It is a new mutation of coronavirus which is very quick to transfer to other people and has a short incubation period as well.
Omicron BF.7: Symptoms and Precautions
The symptoms are similar to previous variants of Covid-19 such as infection of the respiratory tract, fever, cough, sore throat, muscle pain, fatigue, etc.
The first and most important precaution is that people wear masks and take booster doses in crowded areas, and they should avoid going to crowded places completely. Dr VK Paul, Member (Health), NITI Aayog, estimates that 27-28% of India’s population has received the Covid-19 preventive dose to date. The Covid vaccination and booster shots can help you avoid subvariant complications.